Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · opportunities

Boston Scientific discontinues angiographic catheters

31 August 2026 · By · Wire by Fusion42

Published

31 August 2026

Topic

opportunities

◆ Sectors

Medtech

◆ Geography

United States

◆ Source

Read at medtechdive.com →

◆ Verified

Fusion42 · 31 August 2026 · Fusion42 review

Boston Scientific is discontinuing its Imager II Angiographic Catheters due to a manufacturing issue that required pulling the devices from the market.

This Wire brief sits within Fusion42's coverage of Medtech, and 2 sources have reported it between 28 Aug 2026 and 31 Aug 2026.

◆ ◆ The Wire takeaway

Medtech founders focused on angiographic devices must prepare for market gaps as Boston Scientific exits this catheter segment. You need to move fast to target customers left without this product and highlight your reliability.

◆ Coverage

2 sources · first reported 28 Aug 2026 · latest 31 Aug 2026

◆ Related on Wire

◆ Topics

Medtechboston-scientificangiographic-cathetersmanufacturing-issuesproduct-discontinuationmedtech